CANBRIDGE PHARMACEUTICALS INC
(HKEX: 1228)

CANbridge Pharmaceuticals Inc. operates as a rare disease-focused biopharmaceutical company committed to the research, development and commercialization of transformative therapies. The firm's pipeline and products include rare oncology, rare diseases, gene theraphy, Huntercase, Nerlynx, and Caphosol. It operates through the following geographical segment: Mainland China, Taiwan, and Hong Kong. The company was founded by James Xue in 2012 and is headquartered in Beijing, China.

2.600 -

+0.110 (+4.42%)
Range 2.500 - 2.640   (5.60%)
Open 2.550
Previous Close 2.490
Bid Price 2.580
Bid Volume ('000) 47
Ask Price 2.600
Ask Volume ('000) 13
Volume ('000) 1,360
Value 3,516,640
Remark -
Delayed prices. Updated at 10 Mar 2026 16:08.
Data powered by
View All Events


Top Contributors

siacisg avatar
11
Followers 0
Posts 6

Loading Chart...

Please login to view stock data and analysis